Healthcare & Pharmaceuticals

Published by
CorpWatch
|
By |
Eli Lilly charges U.S. customers up to $300 a dose for insulin despite the fact that its production costs are around $10. Unlike most other countries, the U.S. refuses to regulate Big Pharma’s ‘market’ prices. Following a decade of protests, Eli Lilly bowed to pressure and capped U.S. prices at $35 a dose. Read More
Published by
CorpWatch
|
By |
CorpWatch is publishing a guide to over a dozen of the worst companies profiting from healthcare privatization in Europe. Workers are being paid less, clinics are being shut, and worse yet: people's health is suffering and death rates are increasing to line the pockets of investors and top managers. Read More
Published by
CorpWatch
|
By |
La tasa de mortalidad por covid-19 en las residencias de mayores de Madrid gestionadas por las empresas privadas DomusVi y Orpea durante la primera ola de la pandemia fue casi el doble de la tasa en las residencias de mayores de titularidad pública, ilustrado en un nuevo mapa publicado por CorpWatch. Read More
Published by
CorpWatch
|
By |
Hermine Bideaux died of COVID-19 in April 2020 after being rushed to a hospital near the Korian Bel Air eldercare home near Paris, France. Olivia Mokiejewski, her granddaughter, has since filed a manslaughter and endangerment lawsuit against Korian for Hermine’s death, one of many lodged against the company. Read More
Published by
CorpWatch
|
By |
(una versión en español de este artículo se puede leer aquí) In mid-September Juan Carlos López & María del Carmen Florencio took their four-month-old daughter Valentina to Quirónsalud’s hospital in Málaga, Spain, with a fever. Over the next few days, they returned again and again. Each time, the doctors misdiagnosed her. Read More
* indicates required